United States Pharmaceuticals

AMAG Pharmaceuticals Inc (AMAG)

Track

Ticker: AMAG Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 1 Oct 2020
Value US$401,924.11 | Price 262.75 | Shares 66,518 (+5.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2020-10-05 2020-10-01 S Sale
3.0
Camber Capital Management LP
Large shareholder
66,518 +5.4%
262.75
US$401,924 		66,518 +5.4% 262.75 US$401,924
2020-03-18 2020-03-16 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
81,548 +26.6%
21.99
US$3,949,517 		81,548 +26.6% 21.99 US$3,949,517
2020-02-27 2020-02-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
70,759 -45.9%
277.44
US$2,684,418 		70,759 -45.9% 277.44 US$2,684,418
2020-02-27 2020-02-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
24,000 +8.3%
8.29
US$198,960 		24,000 +8.3% 8.29 US$198,960
2020-01-28 2020-01-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
8,000 +2.9%
9.41
US$75,280 		8,000 +2.9% 9.41 US$75,280
2020-01-28 2020-01-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-28 2020-01-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
8,000 +0.2%
9.43
US$75,440 		8,000 +0.2% 9.43 US$75,440
2020-01-28 2020-01-24 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
40,000 +16.7%
9.72
US$388,800 		40,000 +16.7% 9.72 US$388,800
2020-01-28 2020-01-24 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-28 2020-01-24 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
34,000 +0.8%
9.58
US$325,720 		34,000 +0.8% 9.58 US$325,720
2020-01-13 2020-01-10 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-13 2020-01-10 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
18,000 +0.4%
11.64
US$209,520 		18,000 +0.4% 11.64 US$209,520
2020-01-13 2020-01-09 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-13 2020-01-09 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
12,466 +0.3%
12.33
US$153,706 		12,466 +0.3% 12.33 US$153,706
2020-01-13 2020-01-09 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2020-01-13 2020-01-09 S Sale
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
12,466 -0.3%
12.43
US$154,952 		12,466 -0.3% 12.43 US$154,952
2019-08-09 2019-08-09 B Purchase Camber Capital Management LP
3,400 +0.1%
9.18
US$31,206 		3,400 +0.1% 9.18 US$31,206
2019-08-09 2019-08-09 B Purchase Camber Capital Management LP
26,600 +0.6%
8.94
US$237,791 		26,600 +0.6% 8.94 US$237,791
2019-08-09 2019-08-07 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
40,000 +20.0%
7.43
US$297,200 		40,000 +20.0% 7.43 US$297,200
2019-08-09 2019-08-07 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-08-09 2019-08-07 B Purchase ARMISTICE CAPITAL, LLC Large shareholder
260,000 +6.8%
7.32
US$1,903,200 		260,000 +6.8% 7.32 US$1,903,200
2019-08-09 2019-08-07 B Purchase Camber Capital Management LP
4,000 +0.1%
7.58
US$30,300 		4,000 +0.1% 7.58 US$30,300
2019-08-09 2019-08-07 B Purchase Camber Capital Management LP
50,000 +1.2%
7.74
US$387,000 		50,000 +1.2% 7.74 US$387,000
2019-08-09 2019-08-07 B Purchase Camber Capital Management LP
301,000 +7.5%
7.79
US$2,343,496 		301,000 +7.5% 7.79 US$2,343,496
2019-06-27 2019-06-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
20,000 +11.1%
9.47
US$189,400 		20,000 +11.1% 9.47 US$189,400
2019-06-27 2019-06-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-27 2019-06-27 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
44,000 +1.2%
9.52
US$418,880 		44,000 +1.2% 9.52 US$418,880
2019-06-27 2019-06-26 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-27 2019-06-26 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
120,000 +3.3%
9.13
US$1,095,600 		120,000 +3.3% 9.13 US$1,095,600
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
30,000 +20.0%
8.86
US$265,800 		30,000 +20.0% 8.86 US$265,800
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
25,000 +20.0%
8.85
US$221,250 		25,000 +20.0% 8.85 US$221,250
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
0
0.00
US$0 		0 0.00 US$0
2019-06-27 2019-06-25 B Purchase
2.5
ARMISTICE CAPITAL, LLC
Large shareholder
259,016 +7.7%
8.59
US$2,224,947 		259,016 +7.7% 8.59 US$2,224,947
2019-05-29 2019-05-28 B Purchase
Krop Julie

Chief Medical Officer
10,000 +14.0%
9.91
US$99,100 		10,000 +14.0% 9.91 US$99,100
2019-05-09 2019-05-09 B Purchase
Bolgiano Elizabeth Scott

Chief Human Resources Officer
5,000 +7.2%
10.93
US$54,650 		5,000 +7.2% 10.93 US$54,650
2019-05-09 2019-05-09 B Purchase
3.7
HEIDEN WILLIAM K

President & CEO

Executive Director
10,000 +2.1%
10.70
US$107,000 		10,000 +2.1% 10.70 US$107,000
2019-03-11 2019-03-07 PlS Planned sale
3.0
Vittiglio Joseph

EVP, General Counsel
1,425 -1.8%
14.01
US$19,964 		1,425 -1.8% 14.01 US$19,964
2018-08-08 2018-08-07 PlS Planned sale HEIDEN WILLIAM K

President & CEO

Executive Director
5,000 -1.5%
25.00
US$125,000 		5,000 -1.5% 25.00 US$125,000
2018-06-05 2018-06-04 PlS Planned sale HEIDEN WILLIAM K

President & CEO

Executive Director
20,000 -5.7%
25.00
US$500,000 		20,000 -5.7% 25.00 US$500,000
2018-03-06 2018-03-06 PlS Planned sale Vittiglio Joseph

EVP, General Counsel
770 -1.4%
20.80
US$16,016 		770 -1.4% 20.80 US$16,016
2017-08-30 2017-08-29 PlS Planned sale Vittiglio Joseph

SVP, General Counsel
1,250 -3.6%
16.75
US$20,938 		1,250 -3.6% 16.75 US$20,938
2017-07-14 2017-07-13 PlS Planned sale Krop Julie

SVP Clinical & Regulatory, CMO

Officer
4,938 -14.8%
20.00
US$98,760 		4,938 -14.8% 20.00 US$98,760
2017-05-02 2017-05-01 PlS Planned sale Krop Julie

SVP Clinical & Regulatory, CMO

Officer
1,891 -4.9%
24.45
US$46,235 		1,891 -4.9% 24.45 US$46,235
2016-10-20 2016-10-20 PlS Planned sale Krop Julie

SVP Clinical & Regulatory, CMO

Officer
4,938 -17.3%
24.80
US$122,462 		4,938 -17.3% 24.80 US$122,462
2015-11-10 2015-11-10 B Purchase Fallon John A. Non-Executive Director
3,230 +113.1%
31.20
US$100,776 		3,230 +113.1% 31.20 US$100,776
2015-08-07 2015-08-05 PlS Planned sale THOMAS FRANK E

President & COO

Officer
15,000 -12.1%
66.85
US$1,002,750 		15,000 -12.1% 66.85 US$1,002,750
2015-07-17 2015-07-15 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
20,000 -8.8%
75.00
US$1,500,000 		20,000 -8.8% 75.00 US$1,500,000
2015-06-17 2015-06-15 PlS Planned sale Holmes Scott A

SVP, Finance and Treasurer

Officer
6,234 -10.7%
66.63
US$415,371 		6,234 -10.7% 66.63 US$415,371
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
12,128 -5.5%
71.52
US$867,395 		12,128 -5.5% 71.52 US$867,395
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
4,680 -2.1%
70.69
US$330,829 		4,680 -2.1% 70.69 US$330,829
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
36,550 -13.9%
69.77
US$2,550,094 		36,550 -13.9% 69.77 US$2,550,094
2015-06-08 2015-06-05 PlS Planned sale HEIDEN WILLIAM K

CEO

Executive Director
6,642 -2.5%
68.90
US$457,634 		6,642 -2.5% 68.90 US$457,634
2015-06-08 2015-06-04 S Sale THOMAS FRANK E

President & COO

Officer
7,996 -6.8%
69.76
US$557,801 		7,996 -6.8% 69.76 US$557,801
2015-06-08 2015-06-04 S Sale THOMAS FRANK E

President & COO

Officer
12,004 -9.3%
69.27
US$831,517 		12,004 -9.3% 69.27 US$831,517
2015-06-05 2015-06-03 S Sale Wilson Kenneth H

SVP, Sales and Marketing

Officer
5,388 -17.7%
68.77
US$370,533 		5,388 -17.7% 68.77 US$370,533
2015-06-05 2015-06-03 S Sale Holmes Scott A

SVP, Finance and Treasurer

Officer
22,516 -42.2%
68.88
US$1,550,902 		22,516 -42.2% 68.88 US$1,550,902
2015-01-09 2015-01-09 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
17,493 -0.7%
43.48
US$760,596 		17,493 -0.7% 43.48 US$760,596
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,169 -1.0%
46.00
US$1,157,774 		25,169 -1.0% 46.00 US$1,157,774
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
10,000 -0.4%
46.25
US$462,500 		10,000 -0.4% 46.25 US$462,500
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
55,000 -2.1%
45.90
US$2,524,500 		55,000 -2.1% 45.90 US$2,524,500
2015-01-09 2015-01-08 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
52,338 -1.9%
46.11
US$2,413,305 		52,338 -1.9% 46.11 US$2,413,305
2015-01-09 2015-01-07 S Sale ADAGE CAPITAL PARTNERS GP LLC Large shareholder
1,090,000 -28.7%
46.60
US$50,794,000 		1,090,000 -28.7% 46.60 US$50,794,000
2014-02-26 2014-02-26 PlS Planned sale White Christopher G

Chief Business Officer

Officer
400 -1.6%
21.58
US$8,632 		400 -1.6% 21.58 US$8,632
2014-01-09 2014-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
200 -0.8%
22.41
US$4,482 		200 -0.8% 22.41 US$4,482
2014-01-09 2014-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
100 -0.4%
21.40
US$2,140 		100 -0.4% 21.40 US$2,140
2014-01-09 2014-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
1,700 -6.3%
20.61
US$35,037 		1,700 -6.3% 20.61 US$35,037
2014-01-07 2014-01-07 PlS Planned sale White Christopher G

Chief Business Officer

Officer
2,500 -8.0%
24.10
US$60,250 		2,500 -8.0% 24.10 US$60,250
2013-02-26 2013-02-26 PlS Planned sale White Christopher G

Chief Business Officer

Officer
400 -100.0%
16.37
US$6,548 		400 -100.0% 16.37 US$6,548
2013-02-26 2013-02-25 PlS Planned sale White Christopher G

Chief Business Officer

Officer
433 -52.0%
16.39
US$7,097 		433 -52.0% 16.39 US$7,097
2013-01-09 2013-01-09 PlS Planned sale White Christopher G

Chief Business Officer

Officer
3,000 -100.0%
15.80
US$47,407 		3,000 -100.0% 15.80 US$47,407
2013-01-09 2013-01-08 PlS Planned sale White Christopher G

Chief Business Officer

Officer
3,000 -50.0%
15.87
US$47,600 		3,000 -50.0% 15.87 US$47,600
2013-01-07 2013-01-04 PlS Planned sale White Christopher G

Chief Business Officer

Officer
4,000 -40.0%
16.03
US$64,102 		4,000 -40.0% 16.03 US$64,102
2013-01-04 2013-01-03 PlS Planned sale THOMAS FRANK E

EVP, COO

Officer
10,000 -31.2%
15.60
US$155,969 		10,000 -31.2% 15.60 US$155,969
2012-12-06 2012-12-05 PlS Planned sale Holmes Scott A

Chief Accounting Officer

Officer
2,500 -100.0%
14.79
US$36,975 		2,500 -100.0% 14.79 US$36,975
2012-09-13 2012-09-12 PlS Planned sale Holmes Scott A

Chief Accounting Officer

Officer
750 -100.0%
15.54
US$11,655 		750 -100.0% 15.54 US$11,655
Explore more

More insider trading research around AMAG Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America